LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced breast cancer: drug combo targets resistant tumors
Disease control Not yet recruitingThis study tests whether adding entinostat to fulvestrant can help control advanced breast cancer in people whose disease worsened after standard therapy. About 50 women with HR+/HER2- breast cancer will receive the combination. The main goal is to see how long the cancer stays u…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
New hope for advanced breast cancer: YL202 faces off against standard chemo in major trial
Disease control Not yet recruitingThis phase 3 study tests a new drug called YL202 against standard chemotherapy options in people with a common type of advanced breast cancer (HR+/HER2-) that has not responded to at least one prior chemotherapy. The main goal is to see if YL202 can delay cancer growth or improve…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
Could a PET scan replace biopsies for breast cancer patients?
Knowledge-focused Not yet recruitingThis pilot study explores whether a special PET scan using antibodies can predict how well a targeted cancer drug (T-DXd) works in people with advanced breast cancer. The goal is to see if this imaging method can replace the need for tumor biopsies. The study involves 30 patients…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated May 17, 2026 06:48 UTC